cp wire

CP Wire Articles

FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria



Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced on 8/20/18 that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s Biologics License Application (BLA)... read more

Mon, 08/20/18 - 09:59 am
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
  • Ph I trial showed reduction in biomarker associated with anti-tumor activity in animal models
  • There were no serious or dose-limiting adverse events in the Ph I trial
  • Aravive... read more
Mon, 08/20/18 - 09:44 am
Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+
  • The acquisition supports Novo Nordisk's goal to develop glucose responsive insulins
  • ... read more
Fri, 08/17/18 - 09:52 am
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
  • Current dry-powder glucagon formulations must be used immediately because they begin to degrade after reconstitution
  • Xeris’ ready-to-use liquid glucagon is room-temperature stable... read more
Fri, 08/17/18 - 09:24 am
BioNTech to Receive $120 Million Upfront Payment from Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
  • BioNTech will receive $120 million in upfront, equity and near-term research payments
  • Company is elligible for $305 million in additional payments
  • BioNTech has additional... read more
Thu, 08/16/18 - 10:11 am

Pages